Meyer Handelman Company’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Meyer Handelman Company's VRTX Position: Q2 2026 in Review
Meyer Handelman Company held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 575 shares worth $286K. The position accounts for 0.01% of the portfolio, ranked #216.
Meyer Handelman Company first reported a position in VRTX in Q2 2023 and has held it in 8 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Meyer Handelman Company held 575 shares of Vertex Pharmaceuticals worth $286K as of Q2 2026.
- Meyer Handelman Company left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
- Vertex Pharmaceuticals made up 0.01% of Meyer Handelman Company's portfolio in Q2 2026, its #216 holding.
- Meyer Handelman Company first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 8 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Meyer Handelman Company's 13F filing for Q2 2026, filed 3 Aug 2026.